Intranasal corticosteroid use in patients with allergic rhinitis
Allergic rhinitis (AR) is one of the most common diseases in the world, which is based on IgE-mediated inflammation that develops after exposure to various allergens. About 40% of people suffer from the same or other allergic diseases, every third inhabitant of the Earth has symptoms of AR and every...
Saved in:
Main Authors: | Svetlana V. Starostina (Author), Alexey V. Toldanov (Author) |
---|---|
Format: | Book |
Published: |
ZAO "Consilium Medicum",
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis
by: Bridgeman MB
Published: (2017) -
Medication Adherence to Intranasal Corticosteroids in Allergic Rhinitis Patients with Comorbid Medical Conditions
by: Prempreet Kaur Manjit Singh, et al.
Published: (2022) -
Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis
by: Kay Khine Soe, et al.
Published: (2023) -
Comparative study of the efficacy and safety of intranasal azelastine hydrochloride and fluticasone furoate in the treatment of allergic rhinitis
by: Nandish Chennakeshavaraju, et al.
Published: (2020) -
ALLERGIC RHINITIS
by: L.S. Namazova, et al.
Published: (2006)